Difference between revisions of "Periampullary adenocarcinoma"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - " (https:\/\/clinicaltrials.gov\/ct2\/show\/NCT[0-9]{8})" to " [$1 Clinical Trials Registry]") |
Warner-admin (talk | contribs) m (Text replacement - "_99|" to "_999|") |
||
| Line 33: | Line 33: | ||
|1986-1992 | |1986-1992 | ||
|style="background-color:#1a9851"|Phase 3 (C) | |style="background-color:#1a9851"|Phase 3 (C) | ||
| − | |[[#Fluorouracil_. | + | |[[#Fluorouracil_.26_Mitomycin_999|5-FU & Mitomycin]] |
|style="background-color:#ffffbf"|Did not meet primary endpoint of OS | |style="background-color:#ffffbf"|Did not meet primary endpoint of OS | ||
|- | |- | ||
| Line 39: | Line 39: | ||
|2000-2008 | |2000-2008 | ||
|style="background-color:#1a9851"|Phase 3 (C) | |style="background-color:#1a9851"|Phase 3 (C) | ||
| − | |1. [[# | + | |1. [[#FULV_999|FULV]]<br>2. [[#Gemcitabine_monotherapy_999|Gemcitabine]] |
|style="background-color:#ffffbf"|Did not meet primary endpoint of OS | |style="background-color:#ffffbf"|Did not meet primary endpoint of OS | ||
|- | |- | ||
Revision as of 13:16, 18 June 2023
0 regimens on this page
0 variants on this page
|
Note: there is some overlap, especially in the earlier literature, between treatment regimens for periampullary adenocarcinoma and those for pancreatic adenocarcinoma, cholangiocarcinoma, and gallbladder cancer; please see those pages for additional regimens.
Guidelines
ESMO
- 2016: Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. PubMed
NCCN
Adjuvant therapy
Observation
Regimen
| Study | Dates of enrollment | Evidence | Comparator | Comparative Efficacy |
|---|---|---|---|---|
| Takada et al. 2002 | 1986-1992 | Phase 3 (C) | 5-FU & Mitomycin | Did not meet primary endpoint of OS |
| Neoptolemos et al. 2012 (ESPAC-3) | 2000-2008 | Phase 3 (C) | 1. FULV 2. Gemcitabine |
Did not meet primary endpoint of OS |
No adjuvant therapy.
Preceding treatment
References
- Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T; Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002 Oct 15;95(8):1685-95. link to original article PubMed
- ESPAC-3: Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt NC, Dervenis C, Smith D, Glimelius B, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Ghaneh P, Halloran CM, Lerch MM, Oláh A, Rawcliffe CL, Verbeke CS, Campbell F, Büchler MW; European Study Group for Pancreatic Cancer. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA. 2012 Jul 11;308(2):147-56. Erratum in: JAMA. 2012 Nov 14;308(18):1861. link to original article PubMed Clinical Trials Registry